This market develops artificial skin products, including cultured tissues, synthetic scaffolds, and membrane dressings for treating burns, ulcers, and surgical wounds. Growth results from rising chronic wounds and trauma prevalence. Research prioritizes immune tolerance, cellular regeneration, and scar reduction. Market participants consist of biotechnology firms, pharmaceutical companies, and clinical research organizations. Financial and regulatory challenges restrict market speed. Nonetheless, novel therapies provide superior wound healing, infection prevention, and cosmetic improvements, advancing reconstructive medicine worldwide.